UPDATE 1-Ex-drug executive Shkreli's U.S. fraud trial set for June 2017

July 14, 2016 6:59 PM

9 0

NEW YORK, July 14 A federal judge on Thursday scheduled a trial for June 2017 in the U.S. government's securities fraud case against former pharmaceutical executive Martin Shkreli, who became a lightning rod last year for criticism of soaring prescription drug prices.

U.S. District Judge Kiyo Matsumoto, in Brooklyn, New York, set a June 26, 2017, trial date in the case against Shkreli and Evan Greebel, a former lawyer for Retrophin Inc, a biopharmaceutical company which Shkreli headed until 2014.

Also read: Airbnb Won’t Pursue Legal Case Against New York City Over Rental Law

Read more

To category page

Loading...